Basics |
Unity Biotechnology, Inc.
|
IPO Date: |
April 30, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$12.7M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.17 | 3.66%
|
Avg Daily Range (30 D): |
$0.04 | 4.53%
|
Avg Daily Range (90 D): |
$0.07 | 5.00%
|
Institutional Daily Volume |
Avg Daily Volume: |
.46M |
Avg Daily Volume (30 D): |
.11M |
Avg Daily Volume (90 D): |
.16M |
Trade Size |
Avg Trade Size (Sh.): |
201 |
Avg Trade Size (Sh.) (30 D): |
336 |
Avg Trade Size (Sh.) (90 D): |
248 |
Institutional Trades |
Total Inst.Trades: |
85 |
Avg Inst. Trade: |
$1.92M |
Avg Inst. Trade (30 D): |
$.79M |
Avg Inst. Trade (90 D): |
$.79M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.26M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
44.4K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-1.62
|
$-.43
|
$-.5
|
Diluted EPS
|
$-1.62
|
$-.43
|
$-.5
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -27.5M
|
$ -7.3M
|
$ -8.44M
|
Operating Income / Loss
|
$ -30.46M
|
$ -6.89M
|
$ -9.99M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -12.22M
|
$ M
|
$ -1.32M
|
PE Ratio
|
|
|
|
Splits |
Oct 20, 2022:
1:10
|
|